J. Buus Lassen

627 total citations
28 papers, 517 citations indexed

About

J. Buus Lassen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, J. Buus Lassen has authored 28 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in J. Buus Lassen's work include Neurotransmitter Receptor Influence on Behavior (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Receptor Mechanisms and Signaling (6 papers). J. Buus Lassen is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Receptor Mechanisms and Signaling (6 papers). J. Buus Lassen collaborates with scholars based in Denmark, Sweden and United States. J. Buus Lassen's co-authors include Richard F. Squires, J. A. Christensen, Lars Molander, Jacob Lund, Erling N. Petersen, Bengt Långström, Mats Bergström, Lieuwe Appel, Jens Lund and Henrik H. Hansen and has published in prestigious journals such as Biochemical Pharmacology, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

J. Buus Lassen

28 papers receiving 386 citations

Peers

J. Buus Lassen
A. Reyntjens Belgium
P. Placheta Austria
Javaid I. Javaid United States
Marshall B. Wallach United States
Richard C. Ursillo United States
Graham Chen United States
Schellekens Kh
Mark R. Szewczak United States
Eric Eccleston United Kingdom
Melvyn I. Gluckman United States
A. Reyntjens Belgium
J. Buus Lassen
Citations per year, relative to J. Buus Lassen J. Buus Lassen (= 1×) peers A. Reyntjens

Countries citing papers authored by J. Buus Lassen

Since Specialization
Citations

This map shows the geographic impact of J. Buus Lassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Buus Lassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Buus Lassen more than expected).

Fields of papers citing papers by J. Buus Lassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Buus Lassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Buus Lassen. The network helps show where J. Buus Lassen may publish in the future.

Co-authorship network of co-authors of J. Buus Lassen

This figure shows the co-authorship network connecting the top 25 collaborators of J. Buus Lassen. A scholar is included among the top collaborators of J. Buus Lassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Buus Lassen. J. Buus Lassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Appel, Lieuwe, Mats Bergström, J. Buus Lassen, & Bengt Långström. (2013). Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: Dopamine transporter occupancy as measured by PET. European Neuropsychopharmacology. 24(2). 251–261. 25 indexed citations
3.
Lassen, J. Buus. (1989). Nialamide-induced hypermotility in mice treated with inhibitors of monoamine uptake, 5-HT antagonists and lithium. Psychopharmacology. 98(2). 257–261. 1 indexed citations
4.
Lassen, J. Buus. (1989). Introduction to the development of paroxetine, a novel antidepressant. Acta Psychiatrica Scandinavica. 80(S350). 13–13. 2 indexed citations
5.
Lassen, J. Buus, et al.. (1980). Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine. Psychopharmacology. 68(3). 229–233. 23 indexed citations
6.
Lassen, J. Buus. (1979). Inhibition of Apomorphine‐Induced Climbing in Mice by Cholinergic Drugs and Neuroleptics. Acta Pharmacologica et Toxicologica. 45(2). 161–165. 7 indexed citations
7.
Lassen, J. Buus, et al.. (1979). Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine. Psychopharmacology. 64(2). 149–153. 10 indexed citations
8.
9.
Lassen, J. Buus. (1978). Piperoxane reduces the effects of clonidine on aggression in mice and on noradrenaline dependent hypermotility in rats. European Journal of Pharmacology. 47(1). 45–49. 20 indexed citations
10.
Lassen, J. Buus. (1978). Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors. European Journal of Pharmacology. 47(3). 351–358. 87 indexed citations
11.
Lassen, J. Buus. (1977). Inhibition of Apomorphine‐induced Hypermotility in Rats by Chlorpromazinc, Perphenazine, Thioridazine and Melperone. Acta Pharmacologica et Toxicologica. 40(s1). 418–429. 6 indexed citations
12.
13.
Lassen, J. Buus, Richard A. Squires, & Erling N. Petersen. (1975). Neurochemical and pharmacological properties of a new serotonin-potentiating phenylpiperidine derivative FG 4963. Nordisk Psykiatrisk Tidsskrift. 29(6). 475–481. 2 indexed citations
14.
Lassen, J. Buus, Richard F. Squires, J. A. Christensen, & Lars Molander. (1975). Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant properties. Psychopharmacology. 42(1). 21–26. 74 indexed citations
15.
16.
Lassen, J. Buus, et al.. (1975). Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics. European Journal of Pharmacology. 32(1). 108–115. 39 indexed citations
17.
18.
19.
Lassen, J. Buus, J. A. Christensen, Jacob Lund, & Richard F. Squires. (1971). Pharmacological and Biochemical Studies on 2‐Amino‐4‐phenylsulphonylbenzenesulphonamide (NSD 3004): A New Sulphonamide with Anticonvulsant and Carbonic Anhydrase Inhibitory Properties. Acta Pharmacologica et Toxicologica. 30(1-2). 1–16. 3 indexed citations
20.
Lund, Jens & J. Buus Lassen. (1969). Elimination and Distribution of Menbutone (Genabil®) in Rats. Acta Pharmacologica et Toxicologica. 27(2-3). 429–438. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Reyntjens Breakdown of academic impact, for papers by P. Placheta Breakdown of academic impact, for papers by Javaid I. Javaid Breakdown of academic impact, for papers by Marshall B. Wallach Breakdown of academic impact, for papers by Richard C. Ursillo Breakdown of academic impact, for papers by Graham Chen Breakdown of academic impact, for papers by Schellekens Kh Breakdown of academic impact, for papers by Mark R. Szewczak Breakdown of academic impact, for papers by Eric Eccleston Breakdown of academic impact, for papers by Melvyn I. Gluckman
Rankless by CCL
2026